Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Incidence and Mortality of Testicular Cancer and Relationships with Development in Asia

  • Sadeghi, Mostafa (Department of Biostatistics and Epidemiology, Faculty of Health, Tabriz University of Medical Science) ;
  • Ghoncheh, Mahshid (Department of Epidemiology & Biostatistics, School of Public Health, Hamadan University of Medical Sciences) ;
  • Mohammadian-Hafshejani, Abdollah (Department of Social Medicine, School of Medicine, Rafsanjan University of Medical Sciences) ;
  • Gandomani, Hamidreza Sadeghi (Trauma Nursing Research Center, Faculty of Nursing and Midwifery, Kashan University of Medical Sciences) ;
  • Rafiemanesh, Hosein (Trauma Nursing Research Center, Faculty of Nursing and Midwifery, Kashan University of Medical Sciences) ;
  • Salehiniya, Hamid (Zabol University of Medical Sciences)
  • Published : 2016.09.01
⟨ Previous Next ⟩

Abstract

Background: Testicular cancer is one of the most common cancers among young men between ages 20-34 in countries with high or very high levels of the Human Development Index (HDI). This study investigated the incidence and mortality of prostate cancer and the relationship with the HDI and its dimensions in Asia in 2012. Materials and Methods: The study was conducted based on data from the world data of cancer and the World Bank (including the HDI and its components). Standardized incidence and mortality rates of testicular cancer were calculated for Asian countries. Correlations between incidence and/ormortality rates, and the HDI and its components were assessed with the use of the correlation test, using SPSS software. Results: There was a total of 14902 incidences and 5832 death were recorded in Asian countries in 2012. Among the Asian countries, the five countries with the highest standardized incidence rates of testicular cancer were Israel, Georgia, Turkey, Lebanon and Kazakhstan and the five countries with the highest standardized mortality rates were Turkey, Georgia, Jordan, Cambodia and the Syrian Arab Republic. A positive correlation of 0.382 was observed between the standardized incidence rates of testicular cancer and the HDI (p=0.009). Also a negative correlation of 0.298 between the standardized mortality rate of testicular cancer and the Human Development Index was noted although this relation was statistically non-significant (p=0.052). Conclusions: There is a positive correlation between HDI and the standardized incidence rate of testicular cancer and negative correlation with standardized mortality rate.

Keywords

References

  1. ACS A (2010). Cancer facts and figures 2010. American Cancer Society. Atlanta.
  2. Bray F, Klint A, Gislum M, et al (2010). Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncologica, 49, 644-54. https://doi.org/10.3109/02841860903575315
  3. Capocaccia R, Gatta G, Dal Maso L (2015). Life expectancy of colon, breast and testicular cancer patients. An analysis of US-SEER population-based data. Ann Oncology, 131.
  4. Chia VM, Quraishi SM, Devesa SS, et al (2010). International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiology Biomarkers & Prevention, 19, 1151-9. https://doi.org/10.1158/1055-9965.EPI-10-0031
  5. Cook R (2000). Teaching and promoting testicular selfexamination. Nursing Standard, 14, 48.
  6. Curreri SA, Fung C, Beard CJ. Secondary malignant neoplasms in testicular cancer survivors. Urologic Oncology: Seminars and Original Investigations, 2015. Elsevier, 392-8.
  7. Ferlay J, Soerjomataram I, Ervik M, et al (2016). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 2/2/2016.
  8. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, E359-E86. https://doi.org/10.1002/ijc.29210
  9. Fossa SD, Cvancarova M, Chen L, et al (2011). Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients. J Clin Oncol, 29, 963-70. https://doi.org/10.1200/JCO.2010.32.3204
  10. Ghoncheh M, Mirzaei M, Salehiniya H (2015a). Incidence and Mortality of Breast Cancer and their Relationship with the Human Development Index (HDI) in the World in 2012. Asian Pac J Cancer Prev, 16, 8439-43.
  11. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H (2015b). Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia. Asian Pac J Cancer Prev, 16, 6081-7. https://doi.org/10.7314/APJCP.2015.16.14.6081
  12. Gilligan TD, Seidenfeld J, Basch EM, et al (2010). American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol, 28, 3388-404. https://doi.org/10.1200/JCO.2009.26.4481
  13. Hu QD, Zhang Q, Chen W, et al (2013). Human development index is associated with mortality-to-incidence ratios of gastrointestinal cancers. World J Gastroenterol, 19, 5261. https://doi.org/10.3748/wjg.v19.i32.5261
  14. Klugman J (2010). Human Development Report 2010-20th Anniversary Edition. The Real Wealth of Nations: Pathways to Human Development.
  15. Kuzgunbay B, Yaycioglu O, Soyupak B, et al (2013). Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society. Urologic Oncology: Seminars and Original Investigations. Elsevier, 386-91.
  16. Mahdavifar N, Ghoncheh M, Pakzad R, et al (2016). Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World. Asian Pac J Cancer Prev, 17, 381-6. https://doi.org/10.7314/APJCP.2016.17.1.381
  17. Malik K (2013). Human development report 2013. The rise of the south: Human progress in a diverse world. The Rise of the South: Human Progress in a Diverse World (March 15, 2013). UNDP-HDRO Human Development Reports.
  18. Myrup C, Wohlfahrt J, Oudin A, et al (2010). Risk of testicular cancer according to birthplace and birth cohort in Denmark. Int J Cancer, 126, 217-23. https://doi.org/10.1002/ijc.24736
  19. Ozbas A, Cavdar I, Findik U, et al (2010). Inadequate knowledge levels of Turkish male university students about testicular self-examination. Asian Pac J Cancer Prev, 12, 919-22.
  20. Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al (2015a). The incidence and mortality of lung cancer and their relationship to development in Asia. Transl Lung Cancer Res, 4, 763-74.
  21. Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al (2015b). The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int, 3, 135-40. https://doi.org/10.1016/j.prnil.2015.09.001
  22. Patel AR, Prasad SM, Shih Y-CT, et al (2012). The association of the human development index with global kidney cancer incidence and mortality. J Urol, 187, 1978-83. https://doi.org/10.1016/j.juro.2012.01.121
  23. Ramim T, Mousavi SQ, Rosatmnia L, et al (2014). Student knowledge of Testicular cancer and self-examination in a medical sciences University in Iran. Basic Clin Cancer Res, 6, 7-11.
  24. Ray K, Mandal S (2004). Knowledge of cancer in West Bengal-a pilot survey. Asian Pac J Cancer Prev, 5, 205-12.
  25. Rosen A, Jayram G, Drazer M, et al (2011). Global trends in testicular cancer incidence and mortality. European Urol, 60, 374-9. https://doi.org/10.1016/j.eururo.2011.05.004
  26. Sankaranarayanan R, Swaminathan R, Black R (1996). Global variations in cancer survival. Cancer, 78, 2461-4. https://doi.org/10.1002/(SICI)1097-0142(19961215)78:12<2461::AID-CNCR2>3.0.CO;2-N
  27. Shallwani K, Ramji R, Ali TS, et al (2010). Self examination for breast and testicular cancers: a community-based intervention study. Asian Pac J Cancer Prev, 11.
  28. Shanmugalingam T, Soultati A, Chowdhury S, et al (2013). Global incidence and outcome of testicular cancer. Clinical epidemiol, 5, 417.
  29. Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al (2012). Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 380, 1840-50. https://doi.org/10.1016/S0140-6736(12)60919-2
  30. Sui W, Morrow DC, Bermejo CE, et al (2015). Trends in testicular cancer survival: a large population-based analysis. Urol, 85, 1394-8. https://doi.org/10.1016/j.urology.2015.03.022
  31. Tan G, Azrif M, Shamsul A, et al (2011). Clinicopathological Features and Survival of Testicular Tumours in a Southeast Asian University Hospital: A Ten-year. Asian Pacific Journal of Cancer Prevention, 12, 2727-30.
  32. Wynd CA (2002). Testicular self-examination in young adult men. J Nurs Scholarship, 34, 251-5. https://doi.org/10.1111/j.1547-5069.2002.00251.x
  33. Yousif L, Blettner M, Hammer GP, et al (2010). Testicular cancer risk associated with occupational radiation exposure: a systematic literature review. J Radiological Protect, 30, 389. https://doi.org/10.1088/0952-4746/30/3/R01
  34. Znaor A, Lortet-Tieulent J, Jemal A, et al (2014). International variations and trends in testicular cancer incidence and mortality. Eur Urol, 65, 1095-106. https://doi.org/10.1016/j.eururo.2013.11.004